Skip to main content

Tim Anderson

Stock Analyst at National Bank

Total Price Targets
8
Stocks Covered
7
Sectors
Healthcare
Most Recent
Dec 1, 2025

Notable Calls (Last 12 Months)

Most Bullish

  • LLY+21.6%
    Eli Lilly and Company
    $1286.00 targetDec 1, 2025
  • PFE+3.1%
    Pfizer Inc.
    $28.00 targetOct 1, 2025

Most Bearish

  • PFE+3.1%
    Pfizer Inc.
    $28.00 targetOct 1, 2025
  • LLY+21.6%
    Eli Lilly and Company
    $1286.00 targetDec 1, 2025

Stocks Covered by Tim Anderson

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
LLYEli Lilly and Company$1286.00$961.67+33.7%1Dec 1, 2025
PFEPfizer Inc.$28.00$26.38+6.1%2Oct 1, 2025
CAHCardinal Health, Inc.$127.00$195.04-34.9%1Apr 12, 2023
BIIBBiogen Inc.$217.00$186.69+16.2%1Feb 4, 2022
AMGNAmgen Inc.$230.00$328.69-30.0%1Nov 3, 2021
MRKMerck & Co., Inc.$94.00$111.89-16.0%1Oct 29, 2021
ABBVAbbVie Inc.$127.00$206.29-38.4%1May 3, 2021

Recent Activity

  • Dec 1, 2025— Set$1286.00price target onLLY(Eli Lilly and Company)
  • Oct 1, 2025— Set$28.00price target onPFE(Pfizer Inc.)
  • Apr 12, 2023— Set$127.00price target onCAH(Cardinal Health, Inc.)
  • Feb 4, 2022— Set$217.00price target onBIIB(Biogen Inc.)
  • Nov 3, 2021— Set$230.00price target onAMGN(Amgen Inc.)
  • Nov 3, 2021— Set$46.00price target onPFE(Pfizer Inc.)
  • Oct 29, 2021— Set$94.00price target onMRK(Merck & Co., Inc.)
  • May 3, 2021— Set$127.00price target onABBV(AbbVie Inc.)

Frequently Asked Questions

Who is Tim Anderson?

Tim Anderson is a stock analyst at National Bank covering 7 stocks primarily in Healthcare. They have issued 8 price targets since May 3, 2021.

What stocks does Tim Anderson cover?

Tim Anderson currently covers 7 stocks, including PFE, LLY, CAH, BIIB, AMGN.

What is Tim Anderson's latest price target?

Tim Anderson's most recent price target was $1286.00 on LLY (Eli Lilly and Company), set on Dec 1, 2025.

What is Tim Anderson's highest price target?

Tim Anderson's highest issued price target is $1286.00 on LLY, set on Dec 1, 2025.

Coverage based on publicly published price targets. Not investment advice.